#leqembi
Live, measured metrics for the hashtag #leqembi from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #leqembi
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · mas.to (Mastodon public tags API) · fetched 2026-10-15 18:53 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · mas.to (Mastodon public search API) · fetched 2026-10-15 18:53 UTCLive pulse
measured · mas.to (Mastodon tag timeline) · fetched 2026-10-15 18:53 UTCEverything below is measured over the latest 35 public posts (spanning ~32625 hours).
Posting hours (UTC) — busiest: 04:00
Languages: English (25) · German (6) · Italian (2) · Spanish (1) · Chinese (1)
Avg boosts / post: 0.6
Top of the latest posts
#GuteNachrichtenSamstag ⚕️ "#Demenz: US-Arzneibehörde lässt Medikament zur Behandlung von Alzheimer zu" "Das Medikament #Leqembi soll das Fortschreiten von #Alzheimer deutlich verlangsamen. Es wurde nun im Eilverfahren in den #USA zugelasse
https://www.europesays.com/es/787597/ Identifican proteínas sanguíneas que podrían medir los efectos de un tratamiento contra el Alzheimer #alzheimer #biomarcadores #ES #España #Health #lecanemab #leqembi #ProteínaAmiloide #Salud #Spain #Th
https://www.europesays.com/it/669574/ Alzheimer, qualcosa sta cambiando davvero: il test che può “vedere” la malattia prima dei sintomi #Adacanumab #APOEε4 #donanemab #FaustoFantò #Health #IT #Italia #Italy #Kisunla #lecanemab #Leqembi #orb
What “leqembi” means
WikipediaLecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of mild Alzheimer's disease. Lecanemab is an amyloid beta-directed antibody. It is given via intravenous infusion or subcutaneous injection. In clinical trials, it demonstrated small or no clinically significant efficacy in Alzheimer's disease. The most common side effects of lecanemab include headache, infusion-related reactions, and amyloid-related imaging abnormalities, a side effect known
“Lecanemab” on Wikipedia (CC BY-SA) →#leqembi across platforms
every network with a public tag surfaceFollow #leqembi straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/leqembi